GCFC2
Basic information
Region (hg38): 2:75652000-75710985
Previous symbols: [ "TCF9", "C2orf3" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (85 variants)
- not_provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GCFC2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003203.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 77 | 86 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 77 | 9 | 1 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GCFC2 | protein_coding | protein_coding | ENST00000321027 | 17 | 58990 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.56e-24 | 0.00315 | 125470 | 2 | 276 | 125748 | 0.00111 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.00392 | 377 | 377 | 0.999 | 0.0000178 | 5115 |
Missense in Polyphen | 94 | 100.66 | 0.93386 | 1388 | ||
Synonymous | -1.49 | 154 | 132 | 1.16 | 0.00000624 | 1398 |
Loss of Function | 0.655 | 39 | 43.7 | 0.893 | 0.00000228 | 543 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00215 | 0.00212 |
Ashkenazi Jewish | 0.000842 | 0.000695 |
East Asian | 0.00146 | 0.00141 |
Finnish | 0.0000473 | 0.0000462 |
European (Non-Finnish) | 0.00114 | 0.00109 |
Middle Eastern | 0.00146 | 0.00141 |
South Asian | 0.00231 | 0.00206 |
Other | 0.000709 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Factor that represses transcription. It binds to the GC- rich sequences (5'-GCGGGGC-3') present in the epidermal growth factor receptor, beta-actin, and calcium-dependent protease promoters. Involved in pre-mRNA splicing through regulating spliceosome C complex formation. May play a role during late-stage splicing events and turnover of excised inrons. {ECO:0000269|PubMed:24304693}.;
Recessive Scores
- pRec
- 0.189
Intolerance Scores
- loftool
- rvis_EVS
- 1.51
- rvis_percentile_EVS
- 95.47
Haploinsufficiency Scores
- pHI
- 0.0801
- hipred
- N
- hipred_score
- 0.146
- ghis
- 0.408
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gcfc2
- Phenotype
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;spliceosomal complex assembly;mRNA splicing, via spliceosome;regulation of transcription, DNA-templated;negative regulation of transcription, DNA-templated
- Cellular component
- nucleus;nucleoplasm;nucleolus;cytosol;U2-type post-mRNA release spliceosomal complex
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;protein binding